The present invention relates to substituted amino-benzimidazoles of general formula (1) wherein the groups R1 to R14 and A, are defined as in the specification and claims and the use thereof for the treatment of Alzheimer's disease (AD) and similar diseases.
本发明涉及一般式(1)中的取代
氨基
苯并咪唑,其中基团R1至R14和A如规范和索赔中定义,并其用于治疗阿尔茨海默病(AD)和类似疾病。